HERDOO2 may guide duration of treatment for unprovoked VTE
August 30, 2017
Can HERDOO2 guide anticoagulation cessation in women with unprovoked venous thromboembolism (VTE)?
VIDEO: Rivaroxaban plus aspirin cut cardiovascular events in stable patients
August 28, 2017
BARCELONA – The COMPASS trial produced “unambiguous results that should change guidelines and the management of stable coronary artery disease,” commented Eugene Braunwald, MD.
Undiagnosed AF common in higher-risk patients
August 26, 2017
Patients at high risk of atrial fib and stroke commonly have undiagnosed AF.
PVC phlebitis rates varied widely, depending on assessment tool
August 21, 2017
Rates also varied within individual instruments because they included several possible case definitions.
New findings from first all-female TAVR registry
August 15, 2017
PARIS – Preprocedural atrial fibrillation is associated with bad outcomes at 1 year.
How to manage submassive pulmonary embolism
August 14, 2017
Use pulmonary angiographic data, clinical stability, and analysis of other comorbid conditions to decide the best treatment modality for an individual patient with submassive pulmonary embolism.
CCDSSs to prevent VTE
July 24, 2017
Do computerized clinical decision support systems (CCDSSs) decrease the risk of venous thromboembolism (VTE) in surgical patients?
Rivaroxaban or aspirin for extended treatment of VTE
July 21, 2017
Is full or lower intensity rivaroxaban better for extended treatment of venous thromboembolism (VTE) as compared to aspirin?
Idarucizumab reversed dabigatran completely and rapidly in study
July 11, 2017
One drug reversed the anticoagulant effect of another completely and rapidly.
Amplatzer devices outperform oral anticoagulation in atrial fib
July 7, 2017
PARIS – Greater net clinical benefit documented in registry.